Ulcerative Colitis News and Research

Latest Ulcerative Colitis News and Research

Pfizer's ORAL Sync Phase 3 study of tofacitinib in moderate-to-severe RA meets primary endpoints

Pfizer's ORAL Sync Phase 3 study of tofacitinib in moderate-to-severe RA meets primary endpoints

NorthShore receives $1.5 million gift to establish center for the study of complex diseases

NorthShore receives $1.5 million gift to establish center for the study of complex diseases

SQI Diagnostics first quarter net loss increases to $2,255,000

SQI Diagnostics first quarter net loss increases to $2,255,000

Final data from 4SC vidofludimus ENTRANCE Phase IIa trial against IBD presented at ECCO IBD Conference

Final data from 4SC vidofludimus ENTRANCE Phase IIa trial against IBD presented at ECCO IBD Conference

USPTO issues patent to Synergy's SP-333 for treatment of IBD

USPTO issues patent to Synergy's SP-333 for treatment of IBD

New method may eliminate colonoscopies

New method may eliminate colonoscopies

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Mystery of 'inactive' defensin solved

Mystery of 'inactive' defensin solved

SQI fourth quarter net loss increases to $2,621,000

SQI fourth quarter net loss increases to $2,621,000

New findings show reduced vitamin D absorption in patients with quiescent CD

New findings show reduced vitamin D absorption in patients with quiescent CD

Harbor Biosciences signs development agreements for HE2000, HE3235 and HE3286 with CIPI

Harbor Biosciences signs development agreements for HE2000, HE3235 and HE3286 with CIPI

Gut bacteria may play a role in weight loss and gastrointestinal problems: New research

Gut bacteria may play a role in weight loss and gastrointestinal problems: New research

WellApps releases Colonoscopy Prep Assistant

WellApps releases Colonoscopy Prep Assistant

Athersys completes patient enrollment in MultiStem Phase I study for leukemia

Athersys completes patient enrollment in MultiStem Phase I study for leukemia

Altheus Therapeutics announces completion of Zoenasa phase I trial for ulcerative colitis

Altheus Therapeutics announces completion of Zoenasa phase I trial for ulcerative colitis

Avaxia Biologics generates compelling pre-clinical data in animal models of IBD

Avaxia Biologics generates compelling pre-clinical data in animal models of IBD

GLUMETZA tablets are now available to wholesalers and physicians

GLUMETZA tablets are now available to wholesalers and physicians

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

4SC AG's Phase IIb study evaluates efficacy of vidofludimus in RA patients

4SC AG's Phase IIb study evaluates efficacy of vidofludimus in RA patients

Key inhibitory role for IL-1 signaling pathway in human innate immune system

Key inhibitory role for IL-1 signaling pathway in human innate immune system

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.